Fingerprint
Dive into the research topics of 'Phase 2 study of safety and efficacy of nimotuzumab in pediatric Patients with progressive diffuse intrinsic pontine glioma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 study of safety and efficacy of nimotuzumab in pediatric Patients with progressive diffuse intrinsic pontine glioma
Ute Bartels, Johannes Wolff, Lia Gore, Ira Dunkel, Stephen Gilheeney, Jeffrey Allen, Stewart Goldman, Michal Yalon, Roger J. Packer, David N. Korones, Amy Smith, Kenneth Cohen, John Kuttesch, Douglas Strother, Sylvain Baruchel, Janet Gammon, Mark Kowalski, Eric Bouffet
Research output: Contribution to journal › Article › peer-review
33
Scopus
citations